Palvella Therapeutics (PVLA) Profit After Tax (2016 - 2024)
Historic Profit After Tax for Palvella Therapeutics (PVLA) over the last 12 years, with Q4 2024 value amounting to -$4.0 million.
- Palvella Therapeutics' Profit After Tax fell 11021.17% to -$4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$17.4 million, marking a year-over-year decrease of 19327.48%. This contributed to the annual value of -$17.4 million for FY2024, which is 19327.48% down from last year.
- According to the latest figures from Q4 2024, Palvella Therapeutics' Profit After Tax is -$4.0 million, which was down 11021.17% from -$6.8 million recorded in Q3 2024.
- Palvella Therapeutics' 5-year Profit After Tax high stood at $38.7 million for Q4 2023, and its period low was -$16.5 million during Q3 2021.
- For the 5-year period, Palvella Therapeutics' Profit After Tax averaged around -$5.8 million, with its median value being -$7.4 million (2022).
- In the last 5 years, Palvella Therapeutics' Profit After Tax crashed by 169551.12% in 2020 and then soared by 57619.69% in 2023.
- Quarter analysis of 5 years shows Palvella Therapeutics' Profit After Tax stood at -$14.4 million in 2020, then skyrocketed by 33.81% to -$9.5 million in 2021, then rose by 14.76% to -$8.1 million in 2022, then surged by 576.2% to $38.7 million in 2023, then tumbled by 110.21% to -$4.0 million in 2024.
- Its Profit After Tax was -$4.0 million in Q4 2024, compared to -$6.8 million in Q3 2024 and -$4.2 million in Q2 2024.